We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Desktop MRI System Designed for Easy Use, Easy-to-Site Preclinical and Molecular Imaging

By LabMedica International staff writers
Posted on 30 Sep 2010
A new easy-to-use 1.0 Tesla desktop magnetic resonance imaging (MRI) scanner combines simplicity with compact dimensions brings preclinical MRI scanning within reach for a wider range of molecular imaging laboratories. More...


Bruker Corp. (Billerica, MA, USA) announced the introduction of the Icon MRI system, with its innovative cryogen-free permanent magnet from Aspect Magnet Technologies (Netanya, Israel) and high-performance Avance III spectrometer technology with industry-leading preclinical MRI software ParaVision from Bruker, the new Icon system delivers powerful performance and ease of use at an attractive price point.

The Icon is a state-of-the-art and cost-effective MRI instrument for routine preclinical and molecular imaging in biomedical and pharmaceutical applications. Bruker's industry standard MRI software ParaVision guarantees access to a wide range of acquisition and processing tools for in vivo and material science MRI applications. Optional software modules enable the Icon to perform the latest MRI applications, such as relaxometry mapping, fast echo-planar imaging, ultra-short echo time lung imaging, or contrast agent research. As an educational tool, students will find the ParaVision software intuitive, whether it is used to perform research-imaging protocols, or to learn programming of MRI methods.

The new compact shielded permanent magnet with its very small footprint results in an easy to site and install MRI system with almost negligible running costs. Even with a field strength of 1 Tesla, the Icon has zero magnetic fringe field enabling safe location of the system in any facility and for use by any operator. No additional magnetic or radiofrequency (RF) shielding is required for the implementation in the lab. Icon benefits from the Avance III sophisticated digital RF architecture as the technologic basis for the latest MRI applications of today's and tomorrow's preclinical questions.

Dr. Wulf I. Jung, managing director of Bruker BioSpin MRI, GmbH, commented, "High-performance desktop MRI systems have the potential to deliver new research applications to the field of preclinical and molecular imaging. The Icon system is aimed at easy, routine MRI workflows with a compact footprint, low running costs, no magnetic stray fields, and push-button imaging performance, based on the latest Bruker spectrometer and software technology, in order to enable new research groups to enter this fascinating field of preclinical and materials MRI.”

Related Links:

Bruker
Aspect Magnet Technologies





Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.